HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Angiotensin-converting enzyme 2 inhibits endoplasmic reticulum stress-associated pathway to preserve nonalcoholic fatty liver disease.

AbstractBACKGROUND:
Previous works indicated that the stress on the endoplasmic reticulum (ER) affected nonalcoholic fatty liver disease (NAFLD). However, there is no clear evident on the effect of the regulation of ER stress by angiotensin-converting enzyme 2 (ACE2) on the prevention of NAFLD.
METHODS:
HepG2 cells were treated with thapsigargin (Tg) or palmitic acid (PA). We analysed ACE2 expression using Western-blotting analyses. ER stress-related proteins were detected in ACE2 knockout mice and Ad-ACE2-treated db/db mice by immunofluorescence or Western-blotting analyses. In ACE2-overexpression HepG2 cells, the triglyceride (TG), total cholesterol (TC), and glycogen content were detected by assay kits. Meanwhile, the expression of hepatic lipogenic proteins (ACCα, SREBP-1c, FAS, and LXRα), enzymes for gluconeogenesis (PEPCK, G6Pase, and IRS2), and IKKβ/NFκB/IRS1/Akt pathway were analysed by Western-blotting analyses.
RESULTS:
ACE2 was significantly increased in Tg/PA-induced cultured hepatocytes. Additionally, ACE2 knockout mice displayed elevated levels of ER stress, while Ad-ACE2-treated db/db mice showed reduced ER stress in liver. Furthermore, activation of ACE2 can ameliorate ER stress, accompanied by decreased TG content, increased intracellular glycogen, and downregulated expression of hepatic lipogenic proteins and enzymes for gluconeogenesis in Tg/PA-induced hepatocytes. As a consequence of anti-ER stress, the activation of ACE2 led to improved glucose and lipid metabolism through the IKKβ/NFκB/IRS1/Akt pathway.
CONCLUSIONS:
This is the first time documented that ACE2 had a notable alleviating role in ER stress-induced hepatic steatosis and glucose metabolism via the IKKβ/NFκB/IRS1/Akt-mediated pathway. This study may further provide insight into a novel underlying mechanism and a strategy for treating NAFLD.
AuthorsXi Cao, Li-Ni Song, Yi-Chen Zhang, Qi Li, Ting-Ting Shi, Fang-Yuan Yang, Ming-Xia Yuan, Zhong Xin, Jin-Kui Yang
JournalDiabetes/metabolism research and reviews (Diabetes Metab Res Rev) Vol. 35 Issue 4 Pg. e3123 (05 2019) ISSN: 1520-7560 [Electronic] England
PMID30604460 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2019 John Wiley & Sons, Ltd.
Chemical References
  • Triglycerides
  • Peptidyl-Dipeptidase A
  • ACE2 protein, human
  • Ace2 protein, mouse
  • Angiotensin-Converting Enzyme 2
Topics
  • Angiotensin-Converting Enzyme 2
  • Animals
  • Endoplasmic Reticulum Stress
  • Gluconeogenesis
  • Hep G2 Cells
  • Humans
  • Lipid Metabolism
  • Male
  • Mice
  • Mice, Knockout
  • Non-alcoholic Fatty Liver Disease (enzymology, etiology, pathology, prevention & control)
  • Peptidyl-Dipeptidase A (physiology)
  • Signal Transduction
  • Triglycerides (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: